The tissue-modelling technology developer has expanded its Osram-backed series C round to $10.3m with cash from Occident Ventures, Falk Strascheg Holding and BayBG.

Having achieved an initial close of $8m in September, the Helmholtz spinout has now closed its series C round at $10.3m.

Existing investors including Institut Mérieux have added $30m to the $55.5m in series C funding secured by the gene-editing technology developer in March.

Rakuten and SBI contributed to the cancer therapy developer's series C round, which was closed with a $134m second tranche.

MIT retail analytics spinout Celect has now raised a total of $25m, having received $15m in an NGP Partners-led round.

Immunotherapy spinout Annexon Biosciences collected funding from Novartis Venture Fund in a series C round that brought its total funding to $154m.

Immunotherapy spinout Annexon Biosciences collected funding from Novartis Venture Fund in a series C round that brought its total funding to $154m.

SoftBank Vision Fund led a series C round for the cancer therapy developer that was also backed by GV and Alexandria Venture Investments.

Airbnb and WeWork both backed the female-only space provider's series C round, bringing its overall funding to more than $117m.

4Paradigm has now won backing from a host of corporates for its technology, which helps clients build AI apps for purposes including financial services.